Literature DB >> 23079712

Clinical implications of EphB4 receptor expression in pancreatic cancer.

Man Li1, Zuowei Zhao.   

Abstract

In the study, we investigated the correlation between EphB4 receptor expression and the angiogenesis of pancreatic cancer. EphB4 receptor is unevenly distributed or distributed with small patches in pancreatic ductal cell cancer. While EphB4 receptor was not expressed in normal pancreatic tissues. It can be observed that the mRNA of EphB4 receptor is high expressed in all 15 cases of pancreatic ductal cell cancer tissues but not expressed in normal pancreatic tissues. Finally, positive correlation was observed between the mRNA expression level of EphB4 receptor and MVD. Immunohistochemical analysis showed that EphB4 receptor protein expression was related to tumor differentiation and clinical stage. It can be observed that MVD is relevant to histological differentiation and clinical stage. EphB4 receptor is correlated to the initiation, progression and tumor angiogenesis. In conclusion, EphB4 receptor maybe a promising targeted goal of antiangiogenic formation, which provides a new approach and method for tumor treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079712     DOI: 10.1007/s11033-012-2224-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  Early detection of pancreatic cancer.

Authors:  Vasco Eguia; Tamas Adam Gonda; Muhammad Wasif Saif
Journal:  JOP       Date:  2012-03-10

Review 2.  EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasis.

Authors:  Hellmut G Augustin; Yvonne Reiss
Journal:  Cell Tissue Res       Date:  2003-08-02       Impact factor: 5.249

3.  EphB4 is developmentally and differentially regulated in blood vessels throughout the forebrain neurogenic niche in the mouse brain: Implications for vascular remodeling.

Authors:  Dannia Colín-Castelán; Bryan V Phillips-Farfán; Gabriel Gutiérrez-Ospina; Alma Lilia Fuentes-Farias; Armida Báez-Saldaña; Patricia Padilla-Cortés; Esperanza Meléndez-Herrera
Journal:  Brain Res       Date:  2011-04-06       Impact factor: 3.252

4.  Targeting tumor architecture to favor drug penetration: a new weapon to combat chemoresistance in pancreatic cancer?

Authors:  Man Yu; Ian F Tannock
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

5.  Coexpression of ephrin-Bs and their receptors in colon carcinoma.

Authors:  Wenbiao Liu; Syed A Ahmad; Young D Jung; Niels Reinmuth; Fan Fan; Corazon D Bucana; Lee M Ellis
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.

Authors:  Philip Kaenel; Caroline Schwab; Kathrin Mülchi; Carlos Wotzkow; Anne-Catherine Andres
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

7.  Relationships among differentiation degree, contrast-enhanced ultrasound and the expression of Ephb4/Ephrinb2 in primary hepatocarcinoma.

Authors:  Xiao Lin Zhu; Peng Chen; Hua Guo; Wen-Jing Hou; Yu Shi; Ti Zhang; Qiang Li; Nin Zhang
Journal:  Hepatogastroenterology       Date:  2012-06

8.  Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium.

Authors:  G Berclaz; A C Andres; D Albrecht; E Dreher; A Ziemiecki; B A Gusterson; M R Crompton
Journal:  Biochem Biophys Res Commun       Date:  1996-09-24       Impact factor: 3.575

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

Review 10.  Eph receptor tyrosine kinases in tumor and tumor microenvironment.

Authors:  Dana Brantley-Sieders; Sonja Schmidt; Monica Parker; Jin Chen
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  6 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  EphB4 regulates the growth and migration of pancreatic cancer cells.

Authors:  Man Li; Jinbo Zhao; Jinjing Qiao; Chen Song; Zuowei Zhao
Journal:  Tumour Biol       Date:  2014-04-15

3.  Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4.

Authors:  Sally-Anne Stephenson; Evelyn L Douglas; Inga Mertens-Walker; Jessica E Lisle; Mohanan S N Maharaj; Adrian C Herington
Journal:  Oncotarget       Date:  2015-04-10

4.  Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.

Authors:  Ling-Dan Dong; Xiang-Lin Cheng; Long Zhou; Qing Huang; Jun-Chuan Li; Cun-Jian Yi
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

Review 5.  EphrinB2-EphB4 Signaling in Neurooncological Disease.

Authors:  Andras Piffko; Christian Uhl; Peter Vajkoczy; Marcus Czabanka; Thomas Broggini
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia.

Authors:  Xiangqiang Liu; Yafang Wang; Li Sun; Jie Min; Jiaming Liu; Di Chen; Hongbo Zhang; Hongwei Zhang; Helong Zhang; Yongan Zhou; Lili Liu
Journal:  Cancer Sci       Date:  2018-03-05       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.